ES356142A1 - Un procedimiento para producir un preparado antibacteriano. - Google Patents

Un procedimiento para producir un preparado antibacteriano.

Info

Publication number: ES356142A1
Authority: ES; Spain
Prior art keywords: silver; carrier; therapeutic agents; containing therapeutic; ointment
Prior art date: 1967-07-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES356142A

Other languages

English (en)

Spanish (es)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Research Corp

Original Assignee

Research Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1967-07-17

Filing date

1968-07-13

Publication date

1970-02-16

1968-07-13 Application filed by Research Corp filed Critical Research Corp

1970-02-16 Publication of ES356142A1 publication Critical patent/ES356142A1/es

Status Expired legal-status Critical Current

Links

229910052709 silver Inorganic materials 0.000 title abstract 11
239000004332 silver Substances 0.000 title abstract 11
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title abstract 10
239000003814 drug Substances 0.000 title 1
229940124597 therapeutic agent Drugs 0.000 title 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
229930182555 Penicillin Natural products 0.000 abstract 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
239000004098 Tetracycline Substances 0.000 abstract 1
RRDRHWJDBOGQHN-JWCTVYNTSA-N [2-[(2s,5r,8s,11s,14r,17s,22s)-17-[(1r)-1-hydroxyethyl]-22-[[(2s)-2-[[(2s,3r)-3-hydroxy-2-[[(2s)-2-[6-methyloctanoyl(sulfomethyl)amino]-4-(sulfomethylamino)butanoyl]amino]butyl]amino]-4-(sulfomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15 Chemical compound CCC(C)CCCCC(=O)N(CS(O)(=O)=O)[C@@H](CCNCS(O)(=O)=O)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCNCS(O)(=O)=O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCNCS(O)(=O)=O)NC(=O)[C@H](CCNCS(O)(=O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(O)(=O)=O)NC1=O RRDRHWJDBOGQHN-JWCTVYNTSA-N 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 abstract 1
229960000603 cefalotin Drugs 0.000 abstract 1
229940108538 colistimethate Drugs 0.000 abstract 1
108700028201 colistinmethanesulfonic acid Proteins 0.000 abstract 1
239000008311 hydrophilic ointment Substances 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
239000007764 o/w emulsion Substances 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
229940049954 penicillin Drugs 0.000 abstract 1
NBYLLBXLDOPANK-UHFFFAOYSA-M silver 2-carboxyphenolate hydrate Chemical compound C1=CC=C(C(=C1)C(=O)O)[O-].O.[Ag+] NBYLLBXLDOPANK-UHFFFAOYSA-M 0.000 abstract 1
-1 silver tetracycline Chemical class 0.000 abstract 1
UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 abstract 1
239000011780 sodium chloride Substances 0.000 abstract 1
GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 abstract 1
QPPBRPIAZZHUNT-UHFFFAOYSA-N sulfamerazine Chemical compound CC1=CC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 QPPBRPIAZZHUNT-UHFFFAOYSA-N 0.000 abstract 1
229960002597 sulfamerazine Drugs 0.000 abstract 1
FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
229960002211 sulfapyridine Drugs 0.000 abstract 1
GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 abstract 1
JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 abstract 1
229960001544 sulfathiazole Drugs 0.000 abstract 1
229940124530 sulfonamide Drugs 0.000 abstract 1
229960002180 tetracycline Drugs 0.000 abstract 1
229930101283 tetracycline Natural products 0.000 abstract 1
235000019364 tetracycline Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

ES356142A 1967-07-17 1968-07-13 Un procedimiento para producir un preparado antibacteriano. Expired ES356142A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US65383067A	1967-07-17	1967-07-17

Publications (1)

Publication Number	Publication Date
ES356142A1 true ES356142A1 (es)	1970-02-16

Family

ID=24622450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES356142A Expired ES356142A1 (es)	1967-07-17	1968-07-13	Un procedimiento para producir un preparado antibacteriano.

Country Status (8)

Country	Link
BE (1)	BE718183A (fr)
DE (1)	DE1792053B1 (fr)
ES (1)	ES356142A1 (fr)
FR (2)	FR1586125A (fr)
GB (2)	GB1240546A (fr)
IE (1)	IE32197B1 (fr)
NL (1)	NL6809794A (fr)
PH (1)	PH10639A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4049802A (en)	1975-03-19	1977-09-20	Research Corporation	Zinc sulfadiazine and its use in the treatment of burns
DE2804931A1 (de) *	1978-02-06	1979-08-16	Fresenius Chem Pharm Ind	Metallsulfadiazine in feinteiliger form
US4384117A (en) *	1980-03-18	1983-05-17	The United States Of America As Represented By The Secretary Of The Army	Silver metachloridine
NZ224087A (en) *	1987-04-01	1990-08-28	Dak Lab As	Topical pharmaceutical compositions containing 4- or 5- amino salicylic acid or a functional derivative thereof
CA2024220A1 (fr) *	1990-08-29	1992-03-01	Don Simmons	Compose contenant de la sulfadiazine d'argent et de la benzocaine pour le traitement des plaies apres une chirurgie au laser
IT1243435B (it) *	1990-10-05	1994-06-10	Altergon Sa	Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
RS44204A (sr)	2001-11-22	2007-06-04	Biovitrum Ab.,	Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
AU2004240885A1 (en) *	2003-05-21	2004-12-02	Biovitrum Ab	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
US7173030B2 (en)	2003-05-21	2007-02-06	Biovitrum Ab	Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
SE0301884D0 (sv) *	2003-06-25	2003-06-25	Biovitrum Ab	New use III
SE0301888D0 (sv) *	2003-06-25	2003-06-25	Biovitrum Ab	New use VII
SE0301882D0 (sv) *	2003-06-25	2003-06-25	Biovitrum Ab	New use I
SE0301886D0 (sv) *	2003-06-25	2003-06-25	Biovitrum Ab	New use V
SE0301885D0 (sv) *	2003-06-25	2003-06-25	Biovitrum Ab	New use IV
WO2004113310A1 (fr) *	2003-06-25	2004-12-29	Biovitrum Ab	Utilisation d'un inhibiteur de compose de type 1 11-b-hydroxysteroide deshydrogenase type 1 destine a faciliter la cicatrisation d'une plaie
BRPI1104620B1 (pt) *	2011-09-09	2020-04-07	Lucia Teixeira De Carvalho	composição farmacêutica para tratamento de queimaduras e lesões da pele e seu processo de preparação

1968
- 1968-07-05 PH PH9358A patent/PH10639A/en unknown
- 1968-07-10 NL NL6809794A patent/NL6809794A/xx unknown
- 1968-07-13 ES ES356142A patent/ES356142A1/es not_active Expired
- 1968-07-15 IE IE83968A patent/IE32197B1/xx unknown
- 1968-07-16 GB GB4945970A patent/GB1240546A/en not_active Expired
- 1968-07-16 GB GB33831/68A patent/GB1240545A/en not_active Expired
- 1968-07-16 FR FR1586125D patent/FR1586125A/fr not_active Expired
- 1968-07-17 BE BE718183D patent/BE718183A/xx not_active IP Right Cessation
- 1968-07-17 DE DE19681792053 patent/DE1792053B1/de active Pending
- 1968-10-11 FR FR169591A patent/FR8146M/fr not_active Expired

Also Published As

Publication number	Publication date
FR1586125A (fr)	1970-02-13
FR8146M (fr)	1970-08-17
GB1240546A (en)	1971-07-28
BE718183A (fr)	1969-01-17
IE32197L (en)	1969-01-17
DE1792053B1 (de)	1971-07-29
NL6809794A (fr)	1969-01-21
PH10639A (en)	1977-07-22
GB1240545A (en)	1971-07-28
IE32197B1 (en)	1973-05-16

Publication	Publication Date	Title
GB1240545A (en)	1971-07-28	Silver-containing therapeutic agents
CA970908A (en)	1975-07-15	Stable aqueous dispersions of optical brightening agents
ES414888A1 (es)	1976-06-01	Metodo de preparar compuestos triciclicos de azufre antia- lergicos.
OA03416A (fr)	1970-12-15	Nouveau dérivé de l'adénine.
DK120731B (da)	1971-07-05	Phytologisk aktivt middel.
AU3317971A (en)	1973-03-15	The use of diphenylsulfones inthe treatment of mareks disease
ES353795A1 (es)	1970-02-01	Un procedimiento para producir una sal de un derivado del dextran.
ES368395A1 (es)	1971-05-01	Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos.
GB1034536A (en)	1966-06-29	Stable solutions of heparin
CA767590A (en)	1967-09-19	Process for treatment of sodium chloride
FR2312M (fr)	1964-02-03	Nouveau sel potassique de toxicité réduite pour le traitement des hypokaliémies : ascorbate de potassium.
FR3014M (fr)	1964-12-21	Agents cytostatiques de toxicité réduite.
CA764516A (en)	1967-08-01	Treatment of toxic copper-containing solutions
FR2510M (fr)	1964-05-04	Nouveau médicament utilisable pour le traitement des infections staphylococciques et analogues.
NL140512B (nl)	1973-12-17	Werkwijze voor de bereiding van 3-aminoalkyl-3-arylindan-1-olen en hun zuuradditiezouten en natrium- en kaliumzouten, alsmede van 1-aminoalkyl-1-arylindenen hieruit.
CA754991A (en)	1967-03-21	Potassium chloride treatment
CA389185A (fr)	1940-06-04	Conservation de substances actives biologiquement
AU216466A (en)	1968-08-29	Improvements inthe treatment of wheat
CA859747A (en)	1970-12-29	Metal salt complexes of imidazolylphosphonothioates
CA698089A (en)	1964-11-17	Vitamin d treatment of rheumatic diseases
AU424350B2 (en)	1969-05-22	Treatment of steel
AU5962469A (en)	1971-02-25	Treatment of chlorine
AU167175B2 (en)	1954-02-18	Treatment of titanium metal sponge
CA396961A (fr)	1941-06-03	Acide organique et sel
AU279036B2 (en)	1964-10-08	Treatment of ferrous metal